Clinical trial of the efficacy and safety of dydrogesterone in dysmenorrhoea patients.
- Conditions
- Dysmenorrhoea
- Registration Number
- JPRN-UMIN000022779
- Lead Sponsor
- Tottori University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 45
Not provided
1.Patients with medical history of serious liver failure or liver disease. 2.Patients with medical history of heart disease or kidney disease 3.Patients with porphyria. 4.Patients with medical history of peptic ulceration. 5.Patients with severe abnormal clinical examination. 6.Patients with asthma bronchial or asthma aspirin-sensitive. 7.Patients with colitis ulcerative or Crohn's disease. 8.Treatment with luteal hormone or follicular hormone-based hormone agents, low dose pill, middle dose pill, GnRH agonist, testosterone derivative, follicular hormone antagonist, aromatase inhibitor, Chinese herbal medicine for dysmenorrhea or within 2 months of initiation of administration 9.Treatment with transvaginal alcohol fixative, surgical therapy by laparotomy or laparoscope within 2 months of initiation of administration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Valuation of total dysmenorrhea score.
- Secondary Outcome Measures
Name Time Method VAS of pain by dysmenorrhea, dysmenorrhea score, objective, adverse experience